Vornado Announces Second Quarter 2016 Financial Results NEW

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Vornado Announces Second Quarter 2016 Financial Results

NEW YORK, NY --(Marketwired - August 01, 2016) - VORNADO REALTY TRUST ( NYSE : VNO ) filed its Form 10-Q for the quarter ended June 30, 2016 today and reported:

Quarter Ended June 30, 2016 Financial Results

NET INCOME attributable to common shareholders for the quarter ended June 30, 2016 was $220.5 million, or $1.16 per diluted share, compared to $165.7 million, or $0.87 per diluted share, for the prior year's quarter. Adjusting net income attributable to common shareholders for the items listed in the table on the following page, net income attributable to common shareholders for the quarters ended June 30, 2016 and 2015 was $72.5 million and $89.1 million, or $0.38 and $0.47 per diluted share, respectively.

FUNDS FROM OPERATIONS attributable to common shareholders plus assumed conversions ("FFO") for the quarter ended June 30, 2016 was $229.4 million, or $1.21 per diluted share, compared to $323.4 million, or $1.71 per diluted share, for the prior year's quarter. Adjusting FFO for the items listed in the table on the following page, FFO for the quarters ended June 30, 2016 and 2015 was $233.0 million and $238.6 million, or $1.23 and $1.26 per diluted share, respectively.

Six Months Ended June 30, 2016 Financial Results

NET INCOME attributable to common shareholders for the six months ended June 30, 2016 was $106.3 million, or $0.56 per diluted share, compared to $250.2 million, or $1.32 per diluted share, for the six months ended June 30, 2015. Adjusting net income attributable to common shareholders for the items listed in the table on the following page, net income attributable to common shareholders for the six months ended June 30, 2016 and 2015 was $115.2 million and $150.0 million, or $0.61 and $0.79 per diluted share, respectively.

FFO for the six months ended June 30, 2016 was $433.1 million, or $2.28 per diluted share, compared to $544.3 million, or $2.87 per diluted share, for the prior year's six months. Adjusting FFO for the items listed in the table on the following page, FFO for the six months ended June 30, 2016 and 2015 was $438.3 million and $441.3 million, or $2.31 and $2.33 per diluted share, respectively.

Supplemental Financial Information

Further details regarding results of operations, properties and tenants can be accessed at the Company's website www.vno.com . Vornado Realty Trust is a fully-integrated equity real estate investment trust.

Certain statements contained herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. For a discussion of factors that could materially affect the outcome of our forward-looking statements and our future results and financial condition, see "Risk Factors" in Part I, Item 1A, of our Annual Report on Form 10-K, as amended, for the year ended December 31, 2015. Such factors include, among others, risks associated with the timing of and costs associated with property improvements, financing commitments and general competitive factors.

(tables to follow)

The following table reconciles our net income to net income, as adjusted and FFO to FFO, as adjusted:

             
             
(Amounts in thousands, except per share amounts)   For the Three Months Ended     For the Six Months Ended  
    June 30,     June 30,  
    2016     2015     2016     2015  
Net income attributable to common shareholders   $ 220,463     $ 165,651     $ 106,300     $ 250,244  
  Per diluted share   $ 1.16     $ 0.87     $ 0.56     $ 1.32  
                                 
Items that impact net income attributable to common shareholders:                                
  Net gains on sale of real estate and residential condominiums   $ 159,830     $ 4,513     $ 160,544     $ 17,240  
  Net income from discontinued operations and sold properties     3,671       5,168       5,316       17,006  
  Acquisition and transaction related costs     (2,904 )     (4,061 )     (7,511 )     (6,042 )
  Default interest on Skyline properties mortgage loan     (2,711 )     -       (2,711 )     -  
  Real estate impairment losses     (49 )     (14,806 )     (165,102 )     (15,062 )
  Reversal of allowance for deferred tax assets (re: taxable REIT subsidiary's ability to utilize NOLs)     -       90,030       -       90,030  
 
  Other     -       433       -       3,154  
      157,837       81,277       (9,464 )     106,326  
Noncontrolling interests' share of above adjustments     (9,837 )     (4,754 )     580       (6,119 )
Items that impact net income attributable to common shareholders, net   $ 148,000     $ 76,523     $ (8,884 )   $ 100,207  
                                 
Net income attributable to common shareholders, as adjusted   $ 72,463     $ 89,128     $ 115,184     $ 150,037  
  Per diluted share   $ 0.38     $ 0.47     $ 0.61     $ 0.79  
                                 
                                 
FFO (1)   $ 229,432     $ 323,381     $ 433,104     $ 544,305  
  Per diluted share   $ 1.21     $ 1.71     $ 2.28     $ 2.87  
                                 
Items that impact FFO:                                
  Acquisition and transaction related costs   $ (2,904 )   $ (4,061 )   $ (7,511 )   $ (6,042 )
  Default interest on Skyline properties mortgage loan     (2,711 )     -       (2,711 )     -  
  FFO from discontinued operations and sold properties     1,794       8,201       3,957       24,796  
  Reversal of allowance for deferred tax assets (re: taxable REIT subsidiary's ability to utilize NOLs)     -       90,030       -       90,030  
  Our share of impairment loss on India real estate venture's non-depreciable real estate     -       (4,502 )     -       (4,502 )
 
  Net gain on sale of residential condominiums     -       -       714       1,860  
  Other     -       433       -       3,154  
      (3,821 )     90,101       (5,551 )     109,296  
Noncontrolling interests' share of above adjustments     238       (5,270 )     339       (6,290 )
Items that impact FFO, net   $ (3,583 )   $ 84,831     $ (5,212 )   $ 103,006  
                                 
FFO, as adjusted   $ 233,015     $ 238,550     $ 438,316     $ 441,299  
  Per diluted share   $ 1.23     $ 1.26     $ 2.31     $ 2.33  
                                   
(1) See page 4 for a reconciliation of our net income to FFO for the three and six months ended June 30, 2016 and 2015.
   
   
VORNADO REALTY TRUST  
OPERATING RESULTS FOR THE THREE AND SIX MONTHS ENDED  
JUNE 30, 2016 AND 2015  
                         
   
(Amounts in thousands, except per share amounts)   For the Three Months Ended     For the Six Months Ended  
    June 30,     June 30,  
    2016     2015     2016     2015  
Revenues   $ 621,708     $ 616,288     $ 1,234,745     $ 1,223,090  
                                 
Income from continuing operations   $ 265,907     $ 215,764     $ 173,583     $ 324,831  
Income (loss) from discontinued operations     2,475       (364 )     3,191       15,815  
Net income     268,382       215,400       176,774       340,646  
Less net income attributable to noncontrolling interests in:                                
  Consolidated subsidiaries     (13,025 )     (19,186 )     (22,703 )     (35,068 )
  Operating Partnership     (14,531 )     (10,198 )     (7,044 )     (15,485 )
Net income attributable to Vornado     240,826       186,016       147,027       290,093  
Preferred share dividends     (20,363 )     (20,365 )     (40,727 )     (39,849 )
Net income attributable to common shareholders   $ 220,463     $ 165,651     $ 106,300     $ 250,244  
                                 
                                 
Income per common share - Basic:                                
  Income from continuing operations, net   $ 1.16     $ 0.88     $ 0.54     $ 1.25  
  Income from discontinued operations, net     0.01       -       0.02       0.08  
  Net income per common share   $ 1.17     $ 0.88     $ 0.56     $ 1.33  
  Weighted average shares outstanding     188,772       188,365       188,715       188,183  
                                 
Income per common share - Diluted:                                
  Income from continuing operations, net   $ 1.15     $ 0.87     $ 0.54     $ 1.24  
  Income from discontinued operations, net     0.01       -       0.02       0.08  
  Net income per common share   $ 1.16     $ 0.87     $ 0.56     $ 1.32  
  Weighted average shares outstanding     189,885       189,600       190,000       189,775  
                                 
                                 
FFO   $ 229,432     $ 323,381     $ 433,104     $ 544,305  
  Per diluted share   $ 1.21     $ 1.71     $ 2.28     $ 2.87  
                                 
FFO, as adjusted   $ 233,015     $ 238,550     $ 438,316     $ 441,299  
  Per diluted share   $ 1.23     $ 1.26     $ 2.31     $ 2.33  
                                 
Weighted average shares used in determining FFO per diluted share     189,885       189,600       190,043       189,775  
                                 

The following table reconciles our net income to FFO:

             
(Amounts in thousands, except per share amounts)   For the Three Months Ended     For the Six Months Ended  
    June 30,     June 30,  
    2016     2015     2016     2015  
Net income attributable to common shareholders   $ 220,463     $ 165,651     $ 106,300     $ 250,244  
  Per diluted share   $ 1.16     $ 0.87     $ 0.56     $ 1.32  
                                 
FFO adjustments:                                
Depreciation and amortization of real property   $ 133,218     $ 129,296     $ 267,339     $ 247,552  
Net gains on sale of real estate     (161,721 )     -       (161,721 )     (10,867 )
Real estate impairment losses     -       -       160,700       256  
Proportionate share of adjustments to equity in net income (loss) of partially owned entities to arrive at FFO:                                
  Depreciation and amortization of real property     38,308       32,282       77,354       68,554  
  Net gains on sale of real estate     (319 )     (4,513 )     (319 )     (4,513 )
  Real estate impairment losses     49       10,304       4,402       10,304  
      9,535       167,369       347,755       311,286  
Noncontrolling interests' share of above adjustments     (588 )     (9,662 )     (21,469 )     (18,109 )
FFO adjustments, net   $ 8,947     $ 157,707     $ 326,286     $ 293,177  
                                 
FFO attributable to common shareholders   $ 229,410     $ 323,358     $ 432,586     $ 543,421  
Convertible preferred share dividends     22       23       43       46  
Earnings allocated to Out-Performance Plan units     -       -       475       838  
FFO attributable to common shareholders plus assumed conversions   $ 229,432     $ 323,381     $ 433,104     $ 544,305  
  Per diluted share   $ 1.21     $ 1.71     $ 2.28     $ 2.87  
                                   

FFO is computed in accordance with the definition adopted by the Board of Governors of the National Association of Real Estate Investment Trusts ("NAREIT"). NAREIT defines FFO as GAAP net income or loss adjusted to exclude net gains from sales of depreciated real estate assets, real estate impairment losses, depreciation and amortization expense from real estate assets and other specified non-cash items, including the pro rata share of such adjustments of unconsolidated subsidiaries. FFO and FFO per diluted share are non-GAAP financial measures used by management, investors and analysts to facilitate meaningful comparisons of operating performance between periods and among our peers because it excludes the effect of real estate depreciation and amortization and net gains on sales, which are based on historical costs and implicitly assume that the value of real estate diminishes predictably over time, rather than fluctuating based on existing market conditions. FFO does not represent net income and should not be considered an alternative to net income as a performance measure. FFO may not be comparable to similarly titled measures employed by other companies. A reconciliation of our net income to FFO is provided above. In addition to FFO, we also disclose FFO, as adjusted. Although this non-GAAP measure clearly differs from NAREIT's definition of FFO, we believe it provides a meaningful presentation of operating performance. Reconciliations of FFO to FFO, as adjusted are provided on page 2 of this press release.

Conference Call and Audio Webcast

As previously announced, the Company will host a quarterly earnings conference call and an audio webcast on Tuesday, August 2, 2016 at 10:00 a.m. Eastern Time (ET). The conference call can be accessed by dialing 888-771-4371 (domestic) or 847-585-4405 (international) and indicating to the operator the passcode 42972201. A telephonic replay of the conference call will be available from 1:00 p.m. ET on August 2, 2016 through September 1, 2016. To access the replay, please dial 888-843-7419 and enter the passcode 42972201#. A live webcast of the conference call will be available on the Company's website at www.vno.com and an online playback of the webcast will be available on the website for 90 days following the conference call.

Contact: Stephen Theriot (201) 587-1000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 190

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 423

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 376

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 355

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 126

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 253

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 313

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 342

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Viatris Launches Cash Tender Offers for Outstanding Notes

Updated Category News Views 56

Viatris Launches Cash Tender Offers for Outstanding Notes Viatris Inc. (NASDAQ: VTRS), a leading player in the global healthcare sector, has initiated tender offers to acquire certain outstanding notes. This move is designed to strengthen its financial framework and enhance returns for its shareholders. Notably, the offers include various senior notes that were originally...

Continue Reading
Coke Florida Launches Joyful Holiday Caravan Across Florida

Updated Category News Views 239

Coke Florida Kicks Off Holiday Spirit with Caravan Tour Coca-Cola Beverages Florida, LLC (Coke Florida) is thrilled to share that its beloved annual "Holiday Caravan" is set to return. This event, which has become an essential part of the holiday season, features the iconic Coca-Cola red delivery truck decked out in festive cheer. Families will enjoy complimentary samples...

Continue Reading
Nexxen to Join RBC Conference, Share Insights on Technology

Updated Category News Views 68

Nexxen's Upcoming Participation at RBC Global Conference Nexxen International Ltd. (AIM/NASDAQ: NEXN), a leading global advertising technology platform, is geared up to take part in a significant event, the RBC Global Technology, Internet, Media and Telecommunications Conference. This event provides a stellar opportunity for companies to connect with investors and share...

Continue Reading
GayVeterans.us Obtains 501(c)(3) Status to Broaden Support

Updated Category News Views 125

GayVeterans.us Achieves 501(c)(3) Tax Exempt Status GayVeteransUS-Inc. has recently been granted 501(c)(3) tax-exempt status, marking a significant milestone for the organization. This designation enables supporters to make tax-deductible contributions, strengthening the community's ability to provide enhanced resources and support. The dedication of veteran volunteers...

Continue Reading
Virbac Expands Portfolio with Acquisition of Felanorm Solution

Updated Category News Views 130

Virbac Enhances Its Offerings with Felanorm Acquisition Virbac has announced a significant acquisition that marks a pivotal moment in its commitment to improving the health and quality of life for senior cats. This globally recognized drug is aimed at treating feline hyperthyroidism, a condition that is becoming increasingly common in older cats. Understanding Feline...

Continue Reading